Key result
The proposed diagnostic test of myoglobinuria for acute myocardial infarction lacks adequate substantiation regarding assay reproducibility at the critical decision point of /100 ml.
Answers are grounded in this paper and cite their sources.
A letter to the editor critiquing the methodology and claims of a proposed diagnostic test for acute myocardial infarction based on myoglobinuria.
To the Editor.— The article by Saranchak and Bernstein, "A New Diagnostic Test for Acute Myocardial Infarction," (228:1251, 1974) raises important questions concerning the proposed method, which we believe must be answered before this procedure can be considered seriously. Although the authors state that quantitation of myoglobinuria is a "much more accurate diagnostic test for infarction than serum levels of glutamic oxaloacetic transaminase, lactic dehydrogenase, or creatine phosphokinase," they fail, in our opinion, to adequately substantiate their statement; hence, their hypothesis is unconvincing.1,2 The lowest myoglobin standard used (5 mg/100 ml) is unfortunately also at the critical decision point used as evidence by the authors for acute myocardial infarction; no information is provided for reproducibility of the assay technique at this critical level, or at levels lower than 5 mg/100 ml. Moreover, the data in Fig 1 indicate that there may be appreciable overlap between patients with arteriosclerotic heart
No takes yet. Share an insight, caveat, or question.
Robert C. Rock (1974) conducted a letter in Acute Myocardial Infarction. Quantitation of myoglobinuria vs. Serum levels of glutamic oxaloacetic transaminase, lactic dehydrogenase, or creatine phosphokinase was evaluated. The proposed diagnostic test of myoglobinuria for acute myocardial infarction lacks adequate substantiation regarding assay reproducibility at the critical decision point of /100 ml.
Synapse has enriched 10 related papers. Consider them for comparative context: